Middle-term evolution of patients with advanced cutaneous T-cell lymphoma treated with high-dose recombinant interleukin-2 [2]

Archives of Dermatology

Volumn 133, Issue 5, 1997, Pages 656-

  Baccard, M ^a   Marolleau, J P ^a   Rybojad, M ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; INTERLEUKIN 2 RECEPTOR; RECOMBINANT INTERLEUKIN 2;

CANCER RECURRENCE; CANCER REGRESSION; CLINICAL ARTICLE; DOSE RESPONSE; HUMAN; LETTER; PRIORITY JOURNAL; SKIN LYMPHOMA; T CELL LYMPHOMA;

EID: 0030924721     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.1997.03890410120021     Document Type: Letter

References (2)